Clinical trial synchronization: Value creation through real-world data
An interview with Kristijan Kahler, executive director of innovation evidence at Novartis While...
New research is challenging long-held assumptions about privacy-preserving record linkage (PPRL). While PPRL remains essential for de-identified data exchange, the study presented during our recent webinar shows that certain token-based approaches...
An interview with Kristijan Kahler, executive director of innovation evidence at Novartis While...
Given its role at the intersection of novel real-world data and emerging technologies, HealthVerity...
Our series on how Privacy Preserving Record Linkage (PPRL) technology can help government agencies...
HealthVerity is proud to partner with Inovalon, the largest closed claims data source in the U.S.,...
In our ongoing series on how Privacy-Preserving Record Linkage (PPRL) technology can help...
Healthcare brand marketing is at a crossroads. With patients taking a more active role in their...
One in eight women in the U.S. will be diagnosed with breast cancer in their lifetime, that’s one...
In case you missed it, at the end of August, the FDA released new guidance on how to approach...
In our series on how Privacy-Preserving Record Linkage (PPRL) technology can help government...
The use of real-world data has been gaining traction in the healthcare and life sciences...
New research is challenging long-held assumptions about privacy-preserving record linkage (PPRL). While PPRL remains essential for de-identified data exchange, the study presented during our recent webinar shows that certain token-based approaches ca...